Note sull'episodio
So much controversy is packed into this relatively short Investigating Ozempic Podcast.
How did the weekly administered Wegovy (semaglutide) drug get approved for the higher dosage of 2.4mg after doing a controversial dosage trial that conducted testing daily rather than weekly. Why did the Government Regulators approve this dosage after expressing some concerns and why did World Scientists publish questions over using higher dosages of Semaglutide (GLP1's) for weight loss? Is it all to do with Gastric side effects?
So many questions for the Global Blockbuster Drug Wegovy and so much to think about over the Christmas break.
Contact
investigatingozempic@gmail.com
Special Note
In this Podcast I am ONLY looking at the WEIGHT LOSS EFFECT of these GLP1 drugs and am not looking at the Diabetic effec ...